X4 Pharmaceuticals
XFOR
XFOR
51 hedge funds and large institutions have $5.33M invested in X4 Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
77% less capital invested
Capital invested by funds: $23.6M → $5.33M (-$18.2M)
81% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 52
Holders
51
Holding in Top 10
–
Calls
$738K
Puts
$40K
Top Buyers
| 1 | +$252K | |
| 2 | +$185K | |
| 3 | +$148K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$136K |
| 5 |
Millennium Management
New York
|
+$132K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$529K | |
| 3 | -$383K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$296K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$248K |
